Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM98NZR)

Drug Name
ATYR1923 Drug Info
Synonyms Efzofitimod
Indication
Disease Entry ICD 11 Status REF
Pulmonary sarcoidosis 4B20.0 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DM98NZR

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuropilin-2 (NRP2) TTRXUVC NRP2_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT05415137) A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis. U.S.National Institutes of Health.
2 Efzofitimod for the Treatment of Pulmonary Sarcoidosis. Chest. 2023 Apr;163(4):881-890.